Stay updated with breaking news from Andrews davis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Citigroup upgraded shares of Silk Road Medical (NASDAQ:SILK – Get Rating) from a neutral rating to a buy rating in a report released on Monday, MarketBeat.com reports. They currently have $50.00 target price on the stock. SILK has been the subject of several other reports. Argus boosted their target price on shares of Silk Road […]
Should You Buy or Sell Silk Road Medical Stock? Get The Latest SILK Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
B. Riley assumed coverage on shares of Silk Road Medical (NASDAQ:SILK – Get Rating) in a report issued on Friday, The Fly reports. The firm set a “buy” rating on the stock. A number of other equities analysts have also issued reports on SILK. Citigroup upgraded shares of Silk Road Medical from a “sell” rating […]
Operator Good day, and thank you for standing by, and welcome to the Silk Road Medical's 2021 Second Quarter Earnings. [Operator Instructions] I would now like to hand the conference over to your speaker today, Caroline Paul, Investor Relations. Please go ahead. Caroline Paul -- Investor Relations Thank you, and thank you all for participating in today's call. Joining me are Erica Rogers, Chief Executive Officer and Lucas Buchanan, Chief Financial Officer and Chief Operating Officer. Earlier today, Silk Road Medical released financial results for the three months ended June 30, 2021. A copy of the press release is available on the company's website. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.